These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794 [TBL] [Abstract][Full Text] [Related]
11. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial. Baker JV; Huppler Hullsiek K; Prosser R; Duprez D; Grimm R; Tracy RP; Rhame F; Henry K; Neaton JD PLoS One; 2012; 7(10):e46894. PubMed ID: 23082133 [TBL] [Abstract][Full Text] [Related]
13. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV. Hileman CO; Turner R; Funderburg NT; Semba RD; McComsey GA AIDS; 2016 Jan; 30(1):65-73. PubMed ID: 26731754 [TBL] [Abstract][Full Text] [Related]
14. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012 [TBL] [Abstract][Full Text] [Related]
15. Prevention of atherosclerosis in patients living with HIV. De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663 [TBL] [Abstract][Full Text] [Related]
16. Lack of effects of statins on high-density lipoprotein subfractions in HIV-1-infected patients receiving protease inhibitors. Bittar R; Aslangul É; Giral P; Assoumou L; Valantin MA; Kalmykova O; Federspiel MC; Cherfils C; Costagliola D; Bonnefont-Rousselot D; C R Biol; 2017 Feb; 340(2):109-113. PubMed ID: 28011249 [TBL] [Abstract][Full Text] [Related]
17. Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. McMahon D; Lederman M; Haas DW; Haubrich R; Stanford J; Cooney E; Horton J; Kelleher D; Ross L; Cutrell A; Lee D; Spreen W; Mellors JW Antivir Ther; 2001 Jun; 6(2):105-14. PubMed ID: 11491415 [TBL] [Abstract][Full Text] [Related]
18. Plasma and breast-milk selenium in HIV-infected Malawian mothers are positively associated with infant selenium status but are not associated with maternal supplementation: results of the Breastfeeding, Antiretrovirals, and Nutrition study. Flax VL; Bentley ME; Combs GF; Chasela CS; Kayira D; Tegha G; Kamwendo D; Daza EJ; Fokar A; Kourtis AP; Jamieson DJ; van der Horst CM; Adair LS Am J Clin Nutr; 2014 Apr; 99(4):950-6. PubMed ID: 24500152 [TBL] [Abstract][Full Text] [Related]
19. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection. El Kamari V; Hileman CO; Gholam PM; Kulkarni M; Funderburg N; McComsey GA Clin Gastroenterol Hepatol; 2019 Feb; 17(3):536-542.e1. PubMed ID: 29908359 [TBL] [Abstract][Full Text] [Related]
20. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Cvetkovic RS; Goa KL Drugs; 2003; 63(8):769-802. PubMed ID: 12662125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]